69
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Surfactant Therapy for Patients with ARDS After Cardiac Surgery

, , , , , , & show all
Pages 265-272 | Received 01 May 2006, Accepted 30 May 2006, Published online: 09 Dec 2008

References

  • Anzueto A., the Exosurf ARDS Sepsis Study Group. Aerosolized surfactant in adults with sepsis-induced ARDS. N. Engl. J. Med 1996; 334: 1417–1421, [INFOTRIEVE], [CSA]
  • Ashbaugh D. G., Bigelow D. B., Petty T. L., et al. Acute respiratory distress in adults. Lancet 1967; l2: 319–323, [CSA], [CROSSREF]
  • Asimakopoulos G., Taylor K. M., Smith P. L. C., et al. Prevalence of acute respiratory distress syndrome after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg 1999; 117: 620–621, [INFOTRIEVE], [CSA]
  • Bautin A., Khubulava G., Kozlov I., et al. Surfactant therapy for post-bypass lung injury. Eur. Respir. J 2002; 38(Suppl)335, 20[CSA]
  • Bautin A., Khubulava G., Osovckich V., et al. Multicentre clinical trial of surfactant-BL for treatment of adult respiratory distress syndrome. Clinical Studies of Medicine in Russia 2002; 2: 8–23, (in Russian)[CSA]
  • Bernard G. R., Artigas A., Brigham K. L., et al. The American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med 1994; 149: 818–824, [INFOTRIEVE], [CSA]
  • Christensen J. T., Aeberhard J. M., Badel P., et al. Adult respiratory distress syndrome after cardiac surgery. Cardiovasc. Surg 1996; 4: 15–21, [CSA], [CROSSREF]
  • Gattinoni L., et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?. Am. J. Respir. Crit. Care Med 1998; 158: 3–11, [INFOTRIEVE], [CSA]
  • Gregory T. J., Steinberg K. P., Spragg R., et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. Resp. Crit. Care Med 1997; 155: 1309–1315, [INFOTRIEVE], [CSA]
  • Gunther A., Siebert C., Schmidt R., et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am. J. Respir. Crit. Care Med 1996; 153: 176–184, [INFOTRIEVE], [CSA]
  • Hermon M., Golej J., Burda G., et al. Surfactant therapy in infants and children: three years experience in a pediatric intensive care unit. Shock 2002; 4: 247–251, [CSA], [CROSSREF]
  • Lachmann B. Surfactant replacement in acute respiratory failure: Animal studies and first clinical trials. Surfactant replacement therapy, B. Lachmann. Springer-Verlag, New York 1987; 212–223
  • Lewis J., Dhillon J., Singh R. S., et al. Exogenous surfactant therapy for pediatric patients with the acute respiratory distress syndrome. Can. Respir. J 1997; 4: 21–26, [CSA]
  • Messent M., Sullivan K., Keogh B. F., et al. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia 1992; 47: 267–268, [INFOTRIEVE], [CSA]
  • Murray J. F., Mattham M. A., Luce J. M., Flick M. R. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis 1988; 138: 720–723, [INFOTRIEVE], [CSA]
  • Nieman G. F., Gatto L. A., Paskanik A. M., et al. Surfactant replacement in the treatment of sepsis-induced adult respiratory distress syndrome in pigs. Crit. Care Med 1996; 24: 1025–1033, [INFOTRIEVE], [CSA], [CROSSREF]
  • Osovskikh V., Seiliev A., Rosenberg O. Exogenous surfactant: a potent drug for gastric content aspiration?. Eur. Respir. J 2002; 38(Suppl)336, 20[CSA]
  • Osovskikh V., Seiliev A., Rosenberg O. ARDSp and ARDSexp: different responses to surfactant administration. Eur. Respir. J 2003; 45(Suppl)551, 22[CSA]
  • Rosenberg O., Bautin A., Osovskich V., et al. When to start surfactant therapy (ST-therapy) of acute lung injury?. Eur. Respir. J 2001; 33(Suppl)153, 18[CSA]
  • Rosenberg O., Bautin A., Osovskikh V., et al. Surfactant therapy for acute and chronic lung diseases. Appl. Cardiopulm. Pathophysiol 2004; 13: 78, [CSA]
  • Rosenberg O., Danilov L., Volchkov V., et al. Pharmacological properties and therapeutic activity of Russian formulations of surfactants. Bull. Exp. Biol. Med 1998; 126: 455–458, (in Russian)[CSA]
  • Rosenberg O., Osovskih V., Bautin A., et al. Surfactant therapy for acute lung injury and other lung diseases. Eur. Respir. J 2003; 45(Suppl)1429, 22[CSA]
  • Satoh D., Matsukawa S., Saishu T., et al. Effect of surfactant on respiratory failure associated with thoracic aneurysm surgery. Crit. Care Med 1998; 10: 1660–1662, [CSA], [CROSSREF]
  • Seeger W., Spragg R. G., Taut F. J. H., et al. Treatment with rSP-C surfactant reduce mortality in ARDS due to primary pulmonary events. Am. J. Respir. Crit. Care Med 2002; 165: A219, [CSA]
  • Spragg R. G. Current Status of Surfactant Treatment of ARDS/ALI. Appl. Cardiopulm. Pathophysiol 2004; 13: 88, [CSA]
  • Taeusch H. W., Lu K., Ramierez-Schrempp D. Improving pulmonary surfactants. Acta Pharmacol Sin. Supplement 2002; 23: 11–15, [CSA]
  • Tarasenko M., Shpakov Ig., Kallistov D., et al. Surfactant therapy – the real chance to survive for patients with severe inhalation injury. Eur. Respir. J 2004; 48(Suppl)4127, 24[CSA]
  • Walmrath D., Grimminger F., Pappret D., et al. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics. Eur Respir. J 2002; 19: 805–810, [INFOTRIEVE], [CSA], [CROSSREF]
  • Wiedemann H., Baughman R., de Boisblanc B., et al. A multicenter trial in human sepsis-induced ARDS of an aerosolized synthetic surfactant (Exosurf). Am. Rev. Respir. Dis 1992; 145(Suppl)A184, [CSA]
  • Willson D. F., Zaritsky A., Bauman L. A., et al. Instillation of calf lung surfactant extract (Calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit. Care Med 1999; 27: 188–195, [INFOTRIEVE], [CSA], [CROSSREF]
  • Wiswell T. E., Smith R. M., Katz L. B., et al. Bronchopulmonary segmental lavage with Surfaxin (KL4-surfactant) for acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med 1999; 160: 1188–1195, [INFOTRIEVE], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.